Matthias Bodenstedt Moon Lake Immunotherapeutics (MLTX) insider trading activity
Matthias Bodenstedt is Chief Financial Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 520,903 shares of MLTX, which is worth approximately $24 Million. The most recent transaction as insider was on Dec 20, 2023, when has been sold 5,264 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $58.34 per share, resulting in proceeds of $307,101. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
521K
0%
3M change
45.73%
12M change
Total Value Held
$24 Million
Matthias Bodenstedt Transaction History
MB
Matthias Bodenstedt
Chief Financial Officer
Zug, V8